Nogo-A restricts long-term potentiation (LTP) at the Schaffer collateral-CA1 pathway in the adult hippocampus via 2 extracellular domains: Nogo-A-Δ20 and Nogo-66. Nogo-66 signals via Nogo Receptor 1 (NgR1) to regulate synaptic function. Whether the NgR1 coreceptors Lingo1 and p75 NTR are involved in the signaling in this context is still not known. Moreover, the intracellular cascade mediating the activity of Nogo-66 in restricting LTP is unexplored. We combine electrophysiology and biochemistry in acute hippocampal slices and demonstrate that a loss of function for Lingo1 results in a significant increase in LTP levels at the Schaffer collateral-CA1 pathway, and that Lingo1 is the NgR1 coreceptor mediating the role of Nogo-66 in restricting LTP. Our data show that p75 NTR is not involved in mediating the Nogo-66 effect on LTP. Moreover, loss of function for p75 NTR and NgR1 equally attenuate LTD, suggesting that p75 NTR might mediate the NgR1-dependent regulation of LTD, independently of Nogo-66. Finally, our results indicate that Nogo-66 signaling limits LTP via the ROCK2-Cofilin pathway to control the dynamics of the actin cytoskeleton. The present results elucidate the signaling pathway activated by Nogo-66 to control LTP and contribute to the understanding of how Nogo-A stabilizes the neural circuits to limit activity-dependent plasticity events in the mature hippocampus.
Introduction
Changes in the strength of neuronal connectivity, defined as functional plasticity are supposed to be the underlying mechanism for learning and memory processes (Kandel 2001) . Specifically, determined activation patterns result in defined long-lasting changes in synaptic strength, namely long-term potentiation (LTP; Bliss and Lomo 1973) and long-term depression (LTD; Dudek and Bear 1992) . Interestingly, a positive correlation has been demonstrated between LTP at the Schaffer collateral-CA1 pathway and hippocampus-dependent memory (Mayford and Kandel 1999) . The vertebrate brain has the ability of maintaining and recalling long-lasting memories while at the same time allowing the acquisition of new information and the formation of new memories. This observation indicates the clear need for maintaining stable the weight of synaptic transmission throughout the memory network coupled with a capacity for further plasticity of synaptic configurations to integrate old with new knowledge (Abraham and Robins 2005) . The molecular mechanisms regulating the tight balance between stability and plasticity of synapses within the mature CNS network are still largely unexplored. In this molecular context, memory suppressor genes (Abel et al. 1998 ) come into play, in particular molecules like Nogo-A.
The membrane protein Nogo-A, originally identified as a myelin-associated inhibitor of axonal regeneration in the adult CNS (Mironova and Giger 2013; Schwab and Strittmatter 2014; Zagrebelsky and Korte 2014) , was shown to act as a neurite outgrowth inhibitor by regulating the actin cytoskeleton at the growth cone (Hsieh et al. 2006; Montani et al. 2009 ). More recently, Nogo-A has been shown to be expressed in the mature CNS by neurons in areas of high plasticity, that is, the hippocampus and the cerebral cortex (Zagrebelsky et al. 2010; Zemmar et al. 2014 ). Indeed, Nogo-A restricts ocular dominance plasticity in the adult visual cortex (McGee et al. 2005) as well as functional and structural plasticity in the motor cortex . In the mature mouse hippocampus, Nogo-A stabilizes the architecture of pyramidal neurons (Zagrebelsky et al. 2010) , and restricts functional plasticity at the Schaffer collateral-CA1 pathway. Indeed, the magnitude of LTP is increased in the hippocampus of a microRNA-mediated Nogo-A knockdown rats (Tews et al. 2013 ) as well as upon acute neutralization of Nogo-A signaling (Delekate et al. 2011; Kempf et al. 2014) . However, what is the molecular mechanism mediating the role of Nogo-A in limiting plasticity in the adult hippocampus remains largely unknown. In this context, recent publications suggest a surface-receptor mediated function of Nogo-A (Kempf et al. 2014; Delekate et al. 2011; Raiker et al. 2010 ) via 2 receptors: the Sphingosine 1-phosphate receptor 2 (S1PR2) specifically binding the Nogo-A-Δ20 domain (Kempf et al. 2014) , and the Nogo Receptor 1 (NgR1) mediating the signaling of the Nogo-66 domain (Raiker et al. 2010; Delekate et al. 2011) . Interestingly, NgR1 lacking a cytoplasmatic domain (Venkatesh et al. 2005) , signals via a heterotrimeric receptor complex including the p75 neurotrophin receptor ( p75 NTR ; Wang et al. 2002) and Lingo1 (Mi et al. 2004) . A role of p75 NTR in regulating activity-dependent synaptic plasticity has been previously shown. Indeed, p75 NTR mutant mice show a deficit in LTD but not in LTP (Rösch et al. 2005; Woo et al. 2005) . Moreover, another NgR1 ligand, OMgp has been shown to regulate LTP in a p75 NTR -independent manner (Raiker et al. 2010) . However, a possible activity of Lingo1 in regulating synaptic plasticity has not been addressed. Moreover, whether and how p75 NTR and
Lingo1 mediate the Nogo-66/NgR1 signaling in regulating synaptic plasticity is still unknown. We address here these questions in the adult mouse hippocampus and show that Lingo1 is a negative regulator of LTP but not of LTD, and that it mediates the Nogo-66 role in restricting LTP. While p75 NTR is not involved in mediating the signaling pathway activated by Nogo-66 in this context, it might cooperate with NgR1 to attenuate LTD, independently of . Furthermore, what is the downstream intracellular pathway mediating the effect of the Nogo-A signaling in restricting LTP is still unexplored. Interestingly, activity-dependent changes in synaptic transmission have been shown to require modifications in the polymeric status of actin within dendritic spines (Rudy 2014) , critical for LTP maintenance (Kim and Lisman 1999; Krucker et al. 2000; Kramár et al. 2006 ) and the formation of long-term memory (Motanis and Maroun 2012) . We addressed here whether Nogo-66/NgR1 signaling might control LTP by modulating actin dynamics and found that indeed Nogo-66 signals via ROCK2-Cofilin pathway to destabilize the actin cytoskeleton thereby affecting the maintenance of LTP.
Materials and Methods

Slice Preparation and Extracellular Recordings
Acute hippocampal slices were prepared from C57BL/6 wild-type or p75 NTRexonIV knock-out mice (von Schack et al. 2001 ) of either sex. Adult mice (P40-P60) were used for LTP and for mGlu receptor-dependent LTD recording, while juvenile mice (P14-P20) were used for the NMDA receptor-dependent LTD. Mice were euthanized with CO 2 and decapitated. All procedures were approved by the animal welfare representative of the TU Braunschweig and the LAVES (Oldenburg, Germany, Az. §4 (02.05) TSchB TU BS). The brain was dissected and incubated for 3 min in 4°C carbogenated (95% O 2 , 5% CO 2 ) high magnesium (Mg  2+ ) artificial cerebrospinal fluid (ACSF) containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 2 mM MgCl 2 , 26 mM NaHCO 3 , 2 mM CaCl 2 , and 25 mM glucose. Of note, 400-µm thick transversal slices were cut with a vibratome (VT 1000S, Leica, Nussloch, Germany). The slices were maintained at room temperature for at least 90 min in a submerged storage chamber with carbogenated high Mg 2+ ACSF. Extracellular recordings were performed in a submerged recording chamber, where the slices were constantly perfused with carbogenated ACSF at a rate of 1.5 mL/min at 32°C. For LTP experiments, slices were perfused with a low Mg 2+ ACSF with the same composition indicated above except for 1 mM MgCl 2 , while for LTD experiments an ACSF containing 124 mM NaCl, 3 mM KCl, 1.25 mM KH 2 PO 4 , 2 mM MgSO 4 , 26 mM NaHCO 3 , 2.5 mM CaCl 2 , and 10 mM glucose was used. To record evoked field excitatory postsynaptic potentials (fEPSPs), a borosilicate glass micropipette (2-10 MΩ) filled with 3 M NaCl was positioned at a depth of approximately 150-200 µm in the stratum radiatum of the hippocampal CA1 region. A monopolar tungsten electrode (WPI, Cat. # TM33B01, 0.1 MΩ) was placed in the stratum radiatum of the CA3 region of the hippocampus to stimulate the Schaffer-collaterals. The 40% and the 60% of the maximum fEPSP slope was set as baseline stimulation before the induction of LTP and LTD, respectively. For baseline recordings, pulses of 0.2 ms duration were applied at a frequency of 0.1 Hz, and the slope of fEPSP was monitored over time. After 20 min of stable baseline, either a LTP or a LTD protocol was applied. LTP was induced by a theta-burst stimulation (TBS) protocol consisting of 3 times repetition of 4 bursts given at 100 Hz repeated 10 times in a 200 ms interval (5 Hz). LTD in adult mice was induced with a paired-pulse low-frequency stimulation (PP-LFS) protocol based on 900 paired pulses given at 1 Hz with a 50 ms inter-stimulus interval. LTD in juvenile mice was induced by using a lowfrequency stimulation (LFS) protocol consisting of 900 pulses given at 1 Hz. The change in slope size after the induction of LTP or LTD were normalized to the average size of the fEPSP slope recorded during the baseline stimulation and set at 100%. Fiber volley (FV) analysis was performed at room temperature by analyzing the change in fEPSP slope size at different FV amplitude ranging from 0.1 to 0.8 mV. The data were plotted as fEPSP slope against FV amplitude. Paired-pulse facilitation (PPF) was performed stimulating the axons with 2 stimuli with different inter-stimulus intervals (ISI) as 10, 20, 40, 80, and 160 ms, and was analyzed dividing the slope of the second fEPSP by the slope of the first fEPSP at different ISI. Adult mice (P40-P60) were used for all FV and PPF experiments.
The raw data were collected, stored, and analyzed with LAB-VIEW (National Instruments, Austin, TX). The statistical analysis was performed by using GraphPad Prism at 55-60 min post TBS or post LFS with a 2-tailed unpaired Student's t-test for the comparison of 2 independent means, or with a one-way analysis of variance (ANOVA) and Tukey's post hoc test for multiple comparisons. Values of P < 0.05 were considered significant and plotted as follows: *P < 0.05, ** P < 0.01. All data are shown as mean ± SEM.
Pharmacology for Electrophysiological Recording
The specific drugs or antibodies listed below were dissolved in 20 mL carbogenated ACSF and the timing of the treatment is specified in each figure. The experimental settings used in this study have been previously shown to ensure the penetration of the antibodies into the acute hippocampal slices (Delekate et al. 2011; Zemmar et al. 2014 ).
Antibodies
The slices were pretreated at room temperature for 1 h before the recording with antibodies dissolved at the final concentration of 5 µg/mL in ACSF containing 0.1 mg/mL BSA to prevent their unspecific binding to the slices. Moreover, to prevent sticking of the antibodies to the tubing, all the experiments were performed by using PharMed Ismaprene tubing (Ismatec). The following antibodies were used: a rabbit polyclonal anti-Lingo1 antibody (ab23631, Abcam) shown to specifically detect (Pernet et al. 2008) and to block the function of Lingo1 in mediating the Nogo-A/NgR1-dependent inhibition of neurite outgrowth, fasciculation and branching (Petrinovic et al. 2010 ) and in regulating neuronal precursor migration (Mathis et al. 2010 ); a goat polyclonal Nogo Receptor/NgR antibody (Cat. # AF1440, R&D Systems) shown to block NgR1 function in mediating the Nogo-A/NgR1 restriction of LTP in the hippocampus (Delekate et al. 2011 ) and motor cortex ); a control antibody (anti BrdU, mIgG1).
Peptide and Inhibitors
The rat Nogo inhibitory peptide Nogo-P4 (Cat. # Nogo-P4, Alpha Diagnostic international) is a 25-amino acid peptide corresponding to part of the 66-amino acid inhibitory Nogo-66 domain of Nogo-A, and was dissolved in PBS and used at the final concentration of 4 µM. The cell-permeable p75 NTR signaling inhibitor (Ishizaki et al. 2000) , was dissolved in distilled water and used at the final concentration of 100 µM. Jasplakinolide (Cat. # 2792, TOCRIS) , that stabilizes preformed actin filaments inhibiting their depolymerization, was dissolved in DMSO and used at the final concentration of 0.2 µM (Rex et al. 2009 ). The equivalent amounts of solvents were used as control for each treatment.
Western Blot Experiments for Cofilin Phosphorylation Analysis
Of note, 6-8 slices treated by bath application with the appropriate drugs (Nogo-P4 peptide; p160ROCK inhibitor Y-27632; control conditions) for different durations of time were pooled in each group. 10-12 isolated CA1 regions per group were dissected from acute hippocampal slices used in electrophysiology experiments 10 min after TBS, and subsequently pooled. Slices were homogenized in 1% Chaps based lysis buffer (30 mM Tris-Cl at pH 7.5, 150 mM NaCl, 1% Chaps) containing Protease Inhibitor (Complete protease inhibitor cocktail tablets, Roche) and Phosphatase Inhibitor (PhosSTOP phosphatase inhibitor cocktail tablets, Roche), and the debris were pelleted by centrifugation (15 000×g for 15 min at 4°C). Protein concentration was measured via Bradford assay. 100 µg of proteins per lane were loaded and separated onto 4%-12% NuPAGE Bis-Tris Mini Gels (Invitrogen), and then transferred onto a PVDF membrane using a semidry blot. The membrane was blocked with 5% BSA in TBS-Tween for 1 h at room temperature and incubated at 4°C overnight with the following primary antibodies diluted in 3% BSA in TBS-Tween: anti-Cofilin (1:10000, ab11062, Abcam), antiphospho-Cofilin (1:500, ab12866, Abcam), and anti-α-Tubulin, (1:10 000, Cat. # 9026, Sigma-Aldrich). The membrane was washed in TBS-Tween and incubated for 1 h at room temperature with the anti-mouse (1:20 000) or anti-rabbit (1:10 000) secondary antibodies conjugated with HRP (Sigma-Aldrich). Immunoreactivity was detected on a X-ray film by chemoluminescence (Luminata Crescendo Western HRP substrate, Millipore) and quantified using ImageJ. After detection of phospho-Cofilin the blot was stripped and reprobed for total Cofilin. The relative optical density of the immunoreactive bands was analyzed with ImageJ software and α-Tubulin was used as loading control. The control treatment was set to 1, and the ratio phospho-protein to total Cofilin was normalized to those in the controls. The statistical analysis was performed by using GraphPad Prism with a oneway ANOVA and Tukey's post hoc test for multiple comparisons. Values of P < 0.05 were considered significant and plotted as follows: *P < 0.05; **P < 0.01, ***P < 0.001. All data are shown as mean ± SEM.
F/G-actin Ratio Assay
The assay was performed according to the manufacturer's instructions (Cytoskeleton, CO, USA). Briefly, 6-8 acute hippocampal slices were pooled in each group and treated by bath application with the appropriate drugs (Nogo-P4 peptide; p160ROCK inhibitor Y-27632; Jasplakinolide; control conditions). The samples were homogenized in lysis and F-actin stabilization buffer containing 100 mM ATP and a protease inhibitor cocktail (Cytoskeleton). Tissue lysates were incubated at 37°C for 10 min and centrifuged for 1 h at 10 5 ×g to separate the F-actin ( pellet) from the G-actin fractions (supernatant). The G-actin supernatant was gently removed and the F-actin pellet was resuspended in F-actin depolymerization buffer (Cytoskeleton). All samples were diluted with loading buffer and equal amounts of both pellet and supernatant samples were loaded into each lane and separated onto 4-12% NuPAGE Bis-Tris Mini Gels (Invitrogen). After the transfer, the PVDF membrane was blocked with 5% not-fat milk for 30 min at room temperature and incubated at 4°C overnight with the anti-actin primary antibody (1:500, Cytoskeleton) diluted in 0.1% not-fat milk in TBS-Tween. The membrane was washed in TBS-Tween and incubated for 1 h at room temperature with the anti-rabbit (1:5000) secondary antibody HRP (Sigma-Aldrich). Immunoreactivity was detected on a X-ray film by chemoluminescence (Luminata Crescendo Western HRP substrate, Millipore). The relative optical density of the immunoreactive bands was analyzed with ImageJ and expressed as the ratio of F-actin to G-actin. The control treatment was set to 1, and the ratio F-actin to G-actin was normalized to the control. For each condition, the assay was performed in duplicate for at least 3 independent samples. The statistical analysis was performed by using GraphPad Prism with a Student's t test. Values of P < 0.05 were considered significant and plotted as *P < 0.05. All data are shown as mean ± SEM.
Results
Nogo-66 is a Negative Regulator of LTP but not of LTD
We questioned whether Nogo-66 regulates long-term plasticity at the Schaffer collateral-CA1 pathway by treating acute hippocampal slices with the 25 amino acid peptide Nogo-P4, shown to mimic the Nogo-66 inhibitory activity on axonal regeneration in vivo (GrandPré et al . 2000) and to inhibit the neurite outgrowth in vitro (Yamashita and Tohyama 2003; Hasegawa et al. 2004; Fujitani et al. 2005) . First, we analyzed whether application of Nogo-P4 peptide affects LTP induced by a TBS protocol. Indeed, application of Nogo-P4 peptide for 10 min around LTP induction resulted in a significant decrease in LTP magnitude when compared with the control treatment (Fig. 1A) . The average potentiation at 55-60 min after TBS was 161.1 ± 12.1 for control/black bar and 128.9 ± 5.3 for Nogo-P4 treatment/white bar ( Fig Figure1. Nogo-66 restricts LTP without altering LTD or short-term plasticity. (A) LTP recordings in acute hippocampal slices from adult mice (P40-P60) after TBS (arrow) and (A′) mean fEPSP at 55-60 min post TBS upon Nogo-P4 peptide application (white circles/bar, 128.9 ± 5.3, n = 9 slices/5 animals) or control (black diamonds/bar, 161.1 ± 12.1, n = 8 slices/5 animals, *P < 0.05) for 10 min around LTP induction (horizontal bar). (B) LTD recordings in acute hippocampal slices from juvenile mice (P14-P20) after LFS (line) and (B′) mean fEPSP at 55-60 min post LFS upon Nogo-P4 peptide application (white circles/bar, 73.7 ± 2.6, n = 8 slices/3 animals) or control (black diamonds/bar, 71.8 ± 2.8, n = 8 slices/3 animals) for the whole experiment (horizontal bar, 95 min) or for 15 min around LTD induction (B′ control, black horizontal-striped bar 80.1 ± 6.1, n = 8 slices/4 animals; Nogo-P4, white vertical-striped bar 84.4 ± 2.3, n = 7 slices/4 animals). (C) LTD recordings in acute hippocampal slices from adult mice (P40-P60) after PP-LFS (line) and (C′) mean fEPSP at 55-60 min post LFS upon application of Nogo-P4 peptide (white circles/bar, 80.7 ± 3.0, n = 6 slices/4 animals) or control (black diamonds/bar, 82.6 ± 2.2, n = 9 slices/6 animals) for the whole experiment (horizontal bar). PPF analysis (D, n = 8 slices/4 animals for control; n = 6 slices/3 animals for Nogo-P4) and FV measurement (E, n = 7 slices/3 animals for control; n = 8 slices/3 animals for Nogo-P4) upon application of Nogo-P4 peptide for 20 min.
Insets in (A), (B), and (C) show representative original traces (1 is 5 min before, 2 is 55 min after TBS/LFS/PP-LFS; vertical scale bar 1 mV, horizontal scale bar 5 ms).
Error bars, SEM.
Next, we investigated whether application of Nogo-P4 peptide modulates LTD at the Schaffer collateral-CA1 pathway. To analyze NMDA receptor-dependent LTD, a LFS protocol was applied to acute hippocampal slices from juvenile (P14-P20) mice. The application of Nogo-P4 peptide for the whole duration of recording did not influence the magnitude of this form of LTD (Fig. 1B , B′ the average depression at 55-60 min after LFS was 71.8 ± 2.8 for control/black bar and 73.7 ± 2.6 for Nogo-P4 treatment/white bar). Similarly, application of Nogo-P4 peptide only around LTD induction did not affect NMDA receptor-dependent LTD ( Fig. 1B′ the average depression at 55-60 min after LFS was 80.1 ± 6.1 for control/black horizontal-striped bar and 84.4 ± 2.3 for Nogo-P4 treatment/white vertical-striped bar). Next, we tested whether a NMDA receptor-independent form of LTD is modulated by application of Nogo-P4 peptide. For this purpose, paired-pulse low frequency stimulation (PPF-LFS) protocol was applied at the Schaffer collateral-CA1 pathway in acute slices from adult (P40-P60) mice resulting in a mGlu receptor-dependent LTD (Kemp et al. 2000; Huber 2000) . The application of Nogo-P4 peptide for the whole duration of recording did not influence the level of mGlu receptor-dependent LTD when compared with the control treatment (Fig. 1C , C′ the average depression at 55-60 min after PP-LFS was 82.6 ± 2.2 for control/black bar and 80.7 ± 3.0 for Nogo-P4 treatment/white bar).
In order to analyze the influence of the application of Nogo-P4 peptide on short-term plasticity, we tested paired pulse facilitation (PPF), as an indicator of a presynaptic calcium-dependent increase in neurotransmitter release. In comparison to the control, bath application of Nogo-P4 peptide for 20 min did not result in any difference at each of the ISIs analyzed (Fig. 1D ). Next, we tested whether the LTP defect observed after application of Nogo-P4 peptide might be due to altered basal synaptic transmission. For this purpose, we compared the FV amplitude, as an indicator of the amount of presynaptic action potential, with the fEPSP slope. Bath application of Nogo-P4 peptide did not affect the FV amplitude to fEPSP slope ratio (Fig. 1E) .
Taken together, these data show a selective role for the Nogo-66 inhibitory domain in limiting LTP magnitude, without affecting basal synaptic transmission as well as other forms of functional plasticity as LTD or paired pulse facilitation.
Lingo1 Mediates the Activity of Nogo-66 on LTP
The transmembrane protein Lingo1 has been shown to be part of the NgR1 receptor complex mediating myelin inhibition (Mi et al. 2004 ). In the next series of experiments, we analyzed whether Lingo1 might be involved in mediating the signaling of Nogo-66 in regulating LTP in the adult mouse hippocampus.
First, we analyzed the role of Lingo1 in regulating LTP at the Schaffer collateral-CA1 pathway by treating acute hippocampal slices with a specific Lingo1 function blocking antibody (Petrinovic et al. 2010; Mathis et al. 2010) . The neutralization of Lingo1 1 h before and during recording resulted in a significant increase of the LTP magnitude when compared with the control treatment ( Fig. 2A , black diamonds versus white circles). Indeed, the average potentiation at 55-60 min after TBS was 148.7 ± 6.6 for control/black bar and 173.2 ± 6.2 for Lingo1 antibody treatment/ white bar ( Fig. 2A′ , P < 0.05).
Next, to assess whether Lingo1 mediates the effect of Nogo-P4 on LTP, the peptide was applied at the beginning of the recording to slices pretreated for 1 h with the anti-Lingo1 antibody. Upon Lingo1 neutralization, the Nogo-P4-induced decrease in LTP was completely prevented (Fig. 2A , light gray triangles versus dark gray squares). Indeed, in the Lingo1 antibody plus Nogo-P4 treated slices the LTP level was comparable to the one in the control treatment ( Fig. 2A , light gray triangles versus black diamonds), revealing that blocking Lingo1 rescues the effect on LTP of a Nogo-P4 peptide application. The average potentiation at 55-60 min after TBS for the single Nogo-P4 treatment (dark gray bar) was 119.2 ± 6.5 while the potentiation for the combined Lingo1 antibody plus Nogo-P4 treatment (light gray bar) was 150.9 ± 4.2 ( Fig. 2A′ , P < 0.01), comparable with that of the control treatment (black bar) that was 148.7 ± 6.6 (Fig. 2A′) . The potentiation observed for the Lingo1 antibody plus Nogo-P4 cotreatment and for the control treatment was not significantly different.
The analysis of presynaptic function, (PPF in Fig. 2B ), or basal synaptic transmission, (FV in Fig. 2C ), upon neutralization of Lingo1 for 1 h revealed no alteration in comparison to the controls.
Taken together, these data show that the NgR1 coreceptor Lingo1 restricts LTP without affecting short-term plasticity or basal synaptic transmission. Because Lingo1 rescues the effect of Nogo-66 inhibitory domain on LTP, we suggest that Lingo1 is the signaling partner of NgR1 mediating the Nogo-66 dependent effect on LTP.
p75
NTR Does not Mediate the Nogo-66-dependent Effect
on LTP
The p75 neurotrophin receptor p75 NTR has been shown to act as a coreceptor mediating NgR1 signaling in regulating axonal regeneration in the mature CNS (Wang et al. 2002) . In addition, it has been shown that p75 NTR knockout mice do not show any impairment of LTP (Rösch et al. 2005; Woo et al. 2005) . A point that has not been addressed so far is whether p75 NTR might be involved in the transduction of the Nogo-66 signaling in negatively regulating LTP. First, we analyzed the role of p75 NTR in regulating LTP at the Schaffer collateral-CA1 pathway by acutely treating hippocampal slices with the cell-permeable p75 NTR signaling inhibitor TATPep5 (Yamashita and Tohyama 2003) . The application of the inhibitor 1 h before and until the end of recording did not significantly change the magnitude of LTP when compared with the control treatment (Fig. 3A , black diamonds versus white circles). Indeed, the average potentiation at 55-60 min after TBS was 158.0 ± 5.8 for control/black bar and 149.8 ± 6.0 for TAT-Pep5 treatment/white bar (Fig. 3A′ ). This finding confirms previous studies using genetic deletion of p75 NTR and showing that it is not necessary for the induction or expression of LTP (Rösch et al. 2005; Woo et al. 2005) . Next, to test whether blocking p75 NTR might rescue the negative effect of Nogo-P4 application on LTP, the peptide was applied to acute hippocampal slices derived from p75 NTR knockout mice.
The application of Nogo-P4 peptide for the whole duration of recording resulted in a significantly lower level of LTP when compared with the control treatment (Fig. 3B , black diamonds versus white circles), reproducing the effect of the Nogo-P4 peptide observed for LTP in wild-type slices (Fig. 1A-A′) . The average potentiation at 55-60 min after TBS was 158.2 ± 5.6 for control/ black bar and 129.7 ± 5.9 for Nogo-P4 treatment/white bar ( Fig. 3B′ , P < 0.01).
Next we analyzed whether presynaptic function and basal synaptic transmission are affected upon blocking p75 NTR . TATPep5 treatment for 1 h did not influence PPF (Fig. 3C) or FV amplitude to fEPSP slope ratio (Fig. 3D) Loss of Function for NgR1 and p75 NTR but not for Lingo1
Attenuates LTD
While a gain-of-function approach for Nogo-66 did not affect NMDAR-and mGluR-dependent LTD (Fig. 1B -B′, C-C′), in NgR1 knockout mice NMDAR-dependent LTD was shown to be attenuated (Lee et al. 2008) , suggesting that this activity of NgR1 might be independent of Nogo-66. Thus, we first confirmed the role of NgR1 in regulating LTD at the Schaffer collateral-CA1 pathway by acutely blocking its function. Indeed, the treatment of acute hippocampal slices 1 h before and during the whole experiment with a NgR function blocking antibody significantly attenuated NMDA receptor-dependent LTD in comparison to the control treatment (Fig. 4A , black diamonds versus white circles). The average depression at 55-60 min after LFS was 80.2 ± 2.9 for control/black bar and 93.9 ± 3.7 for NgR antibody treatment/white bar ( Fig. 4A′ , P < 0.01).
To examine whether the 2 coreceptors of NgR1, p75 NTR and Lingo1, might be involved in modulating LTD at the Schaffer collateral-CA1 pathway, we induced NMDA receptor-dependent LTD using a low frequency stimulation (LFS) protocol to acute hippocampal slices after treatment for 1 h with the inhibitor of p75 NTR TAT-Pep5 or the Lingo1 function blocking antibody. As expected from previous publications (Rösch et al. 2005; Woo et al. 2005) , inhibition of p75 NTR signaling resulted in a significantly attenuated LTD (Fig. 4B , black diamonds versus white circles), mimicking the effect observed after the neutralization of NgR1 (Fig. 4A) . The average depression was 68.5 ± 2.7 for control/black bar and 82.1 ± 2.8 for TAT-Pep5 treatment/white bar ( Fig. 4B′ , P < 0.05). On the other hand, neutralization of Lingo1 did not affect LTD (Fig. 4C , black diamonds versus white circles), as the magnitude of LTD was comparable with that of the control treatment (Fig. 4C′ , the average depression was 81.3 ± 2.5 for control/black bar and 84.0 ± 3.4 for Lingo1 antibody treatment/white bar). Taken together, these data suggest that NgR1 attenuates LTD in a p75 NTR -dependent manner but independently of Lingo1 signaling. 148.7 ± 6.6, n = 12 slices/7 animals) 1 h before and during the whole recording (upper horizontal bar). Application of Nogo-P4 peptide from the beginning of recordings (lower horizontal bar) to slices pretreated for 1 h with Lingo1 antibody (light gray triangles/bar, 150.1 ± 4.2, n = 9 slices/4 animals) or with control antibody (dark gray squares/bar, 119.2 ± 6.5, n = 7 slices/5 animals). Insets, representative original traces (1 is 5 min before, 2 is 55 min after TBS; vertical scale bar 1 mV, horizontal scale bar 5 ms). PPF analysis (B, n = 6 slices/3 animals for control; n = 8 slices/3 animals for Lingo1 antibody) and FV measurements (C, n = 6 slices/3 animals for control; n = 8 slices/3 animals for Lingo1 antibody) upon neutralization of Lingo1 for 1 h. *P < 0.05, **P < 0.01, ***P < 0.001. Error bars, SEM.
Nogo-66 Signaling Regulates Actin Dynamics and Cofilin Activation via ROCK2
Changes in actin dynamics underlie the morphological and functional modifications occurring at dendritic spines (Hotulainen and Hoogenraad 2010) . Due to the crucial role of actin dynamics in mediating processes of activity-dependent plasticity, we assessed whether Nogo-66 signaling regulates actin dynamics within the adult hippocampus. For this purpose, we analyzed the ratio of F/G-actin fractions upon Nogo-66 gain-of function treatment. Bath application of Nogo-P4 peptide to acute hippocampal slices for 20 min significantly decreased the ratio of F/G-actin by −32.1 ± 2.3% when compared with the control, resulting in a shift of the equilibrium between F-and G-actin NTRexonIV knockout mice and (B′) mean fEPSP at 55-60 min post TBS upon application of Nogo-P4 peptide (horizontal bar; white circles/bar, 129.7 ± 5.9, n = 6 slices/3 animals) or control (black diamonds/bar, 158.2 ± 5.6, n = 9 slices/3 animals; **P < 0.01). (C) PPF analysis (n = 7 slices/3 animals for control, n = 8 slices/3 animals for TAT-Pep5) and (D) FV measurement (n = 9 slices/3 animals for control, n = 9 slices/3 animals for TAT-Pep5) upon inhibition of p75 NTR for 1 h. Insets in (A) and (D) show representative original traces (1 is 5 min before, 2 is 55 min after TBS; vertical scale bar 1 mV, horizontal scale bar 5 ms). Error bars, SEM.
toward G-actin ( Fig. 5A , P < 0.05 for black versus dark gray bar). Interestingly, the bath application of Nogo-P4 peptide along with the F-actin stabilizing drug Jasplakinolide for 20 min increased the ratio of F/G-actin by + 16.8 ± 7.0% when compared with the treatment with the peptide alone, clearly indicating a role for Nogo-66 domain in promoting actin depolymerization ( neutralization of NgR1 (white circles/bar, 93.9 ± 3.7, n = 6 slices/3 animals) or control treatment (black diamonds, 80.2 ± 2.9, n = 7 slices/3 animals; **P < 0.01) 1 h before and during the whole recording (horizontal bar). (B) LTD recordings after LFS (line) and (B′) mean fEPSP at 55-60 min post LFS upon inhibition of p75 NTR receptor (white circles/ bar, 82.1 ± 2.8, n = 8 slices/3 animals) or control treatment (black diamonds/bar, 68.6 ± 2.7, n = 5 slices/3 animals; *P < 0.05) 1 h before and during the entire recording treatment with the peptide alone, rescuing the actin depolymerizing effect of Nogo-P4 peptide ( Fig. 5A , P < 0.05 for dark gray versus white bar). This indicates that ROCK2 mediates the role of the Nogo-66 domain in controlling actin dynamics. Among the many actin binding proteins, modulation of the activity of the actin depolymerizing protein Cofilin, a downstream target of ROCK2, has been shown to be essential for the reorganization of the actin cytoskeleton (Bamburg and Bernstein 2010) . Therefore, we assessed whether Nogo-66 signaling might control actin dynamics within the adult hippocampus via the regulation of Cofilin activity. To this aim, we analyzed the level of phosphorylated Cofilin upon a Nogo-66 gain-of-function approach. Bath application of Nogo-P4 peptide to acute hippocampal slices for 20 min significantly decreased the level of phosphorylated Cofilin by −33.9 ± 5.1% when compared with the control treatment, (Fig. 5B , P < 0.05 for black versus dark gray bar), without affecting total protein level (Fig. 5B, upper  panel) . Interestingly, bath application of Nogo-P4 peptide along with the specific p160ROCK inhibitor Y-27632 for 20 min significantly increased the ratio of phospho-Cofilin to Cofilin level by +58.4 ± 18.9% when compared with the treatment of the peptide alone, rescuing the effect of Nogo-P4 peptide on Cofilin phosphorylation to control levels ( Fig. 5B , P < 0.01 for dark gray versus white bar).
Overall, these data show that Nogo-66 signals via ROCK2 in order to increase the activity of Cofilin and by this means, it shifts the F/G-actin ratio toward G-actin.
Nogo-66 Regulates Actin Dynamics via the ROCK2-Cofilin Pathway to Restrict LTP
The expression and maintenance of LTP depends on modifications in the organization of the actin cytoskeleton within dendritic spines (Rudy 2014) . Indeed, LTP induction is followed by the polymerization of actin filaments within dendritic spines (Okamoto et al. 2004) . Our results indicate a role of Nogo-66 signaling in destabilizing the actin cytoskeleton (Fig. 5A ) as well as in restricting LTP (Fig. 1A) . Thus, we next tested whether Nogo-66 signaling may restrict LTP by negatively regulating actin dynamics. To this aim, we first analyzed whether stabilizing the actin cytoskeleton, by application of Jasplakinolide, rescues the decrease in LTP magnitude induced by Nogo-P4 peptide. While Jasplakinolide alone did not affect LTP level (Fig. 6B , the average potentiation at 55-60 min after TBS was 155.6 ± 4.8 for control/ black bar and 145.3 ± 7.1 for Jasplakinolide treatment/light gray vertical-striped bar), its coapplication around LTP induction with the Nogo-P4 peptide completely rescued the decrease in LTP induced by the application of the peptide alone (Fig. 6A , light gray circles versus dark gray squares). Indeed, the average potentiation at 55-60 min after TBS was 168.8 ± 13.3 for the combined Nogo-P4 plus Jasplakinolide treatment/light gray bar, and 128.8 ± 4.2 for the single Nogo-P4 treatment/dark gray bar ( Fig. 6A′ , P < 0.01).
Next, to elucidate the intracellular cascade mediating the activity of Nogo-66 on the actin cytoskeleton during LTP, we used a combined application of Nogo-P4 peptide with the specific p160ROCK inhibitor y-27632 around LTP induction. While the application of the p160ROCK inhibitor y-27632 alone did not affect LTP (Fig. 6B , the average potentiation at 55-60 min after TBS was 155.6 ± 4.8 for control/black bar and 150.8 ± 6.9 for y-27632 treatment/white horizontal-striped bar), coapplication of y-27632 and Nogo-P4 completely rescued the decrease in LTP observed after the application of the peptide alone (Fig. 6A , white triangles versus dark gray squares). Indeed, the average potentiation at 55-60 min after TBS was 166.3 ± 3.9 for the combined Nogo-P4 plus y-27632 treatment/white bar, and 128.8 ± 4.2 for the single Nogo-P4 treatment/dark gray bar (Fig. 6A′, P < 0.01) . Nogo-P4 peptide with the p160ROCK inhibitor y-27632 (white bar, n = 4 independent experiments) for 20 min. * P < 0.05, **P < 0.01. Error bars, SEM. 55-60 min post TBS upon combined application of Nogo-P4 peptide and p160ROCK inhibitor y-27632 (white triangles/bar, 166.3 ± 3.9, n = 7 slices/3 animals), Jasplakinolide (light gray circles/bar, 168.8 ± 13.3, n = 7 slices/3 animals) or application of peptide alone (dark gray squares/bar, 128.8 ± 4.2, n = 9 slices/4 animals) or control treatment Bottom panel: LTP recording after TBS (arrow) upon Nogo-P4 peptide application for 10 min around LTP induction (horizontal bar; n = 10 slices/1 animal for control, n = 11 slices/1 animal for Nogo-P4 treatment). *P < 0.05, **P < 0.01, ***P < 0.001. Error bars, SEM.
Changes in the activity of the actin depolymerizing protein Cofilin are necessary for the expression and maintenance of LTP. Indeed, LTP induction is associated with a transient increase in the phosphorylation-dependent inactivation of Cofilin (Fukazawa et al. 2003; Chen et al. 2007; Gu et al. 2010; Rex et al. 2009 ). As our results show a role of Nogo-66 in regulating Cofilin activity (Fig. 5B) , we also tested whether Nogo-66 regulates the activitydependent phosphorylation of Cofilin upon LTP induction at the Shaffer collateral-CA1 pathway. For this purpose, we analyzed Cofilin phosphorylation levels specifically within the CA1 region of control and Nogo-P4 treated acute hippocampal slices 10 min after TBS (Fig. 6C′) . In control treated slices the level of phosphorylated Cofilin significantly increased 10 min after TBS by + 52.7 ± 9.6% when compared with control treated slices which did not receive TBS (Fig. 6C , black versus light gray bar, P < 0.001), confirming previous reports Gu et al. 2010) . Interestingly, the increase in phospho-Cofilin levels could not be observed in slices where the Nogo-P4 peptide was applied during TBS. Indeed, the level of phosphorylated Cofilin in Nogo-P4 treated slices significantly decreased 10 min after TBS by −54.7 ± 12.5% when compared with control treated slices 10 min after TBS (Fig. 6C , light gray versus dark gray bar, P < 0.001). In all the treatments, the total level of Cofilin protein was not altered (Fig. 6C, upper panel) .
Taken together, our data provide evidence that Nogo-66 signaling affects LTP maintenance by modulating the actin cytoskeleton dynamics during LTP induction. Moreover, because ROCK2 rescues the effect of Nogo-66 on LTP and on the other hand Nogo-66 prevents the activity-dependent phosphorylation of Cofilin, one can conclude that Nogo-66 signals via the activation of ROCK2-Cofilin pathway.
Discussion
Nogo-A has been shown to act as a negative regulator of activitydependent synaptic plasticity in the adult CNS. However, the molecular mechanism mediating this role of Nogo-A are largely unknown. We addressed this question, by investigating the signaling pathway mediating the effect of Nogo-66 on LTP in the CA1 region of the adult mouse hippocampus. Our results indicate that, upon binding of the Nogo-66 domain, NgR1 cooperates with Lingo1 to negatively regulate LTP. In addition, we show that this activity of Nogo-66 depends on the modulation of the activity of the actin-binding protein Cofilin via the Rho-A downstream effector ROCK2 in order to destabilize actin filaments. Finally, our data suggest a NgR1/p75 NTR mediated regulation of LTD independent of Nogo-A. For a scheme, see Figure 7 .
Receptor Signaling Mediating the Role of Nogo-66 on Activity-dependent Synaptic Plasticity
We addressed the role of Nogo-66 in acutely regulating long-and short-term plasticity by using a gain-of-function approach, and we found that the Nogo-66 domain selectively restricts LTP, without affecting LTD or paired-pulse facilitation. This is in line with a previous publication showing that a local application of a Nogo-66 peptide suppresses NMDA receptor-dependent LTP via NgR1-dependent signaling (Raiker et al. 2010) . Similarly, interfering with the Nogo-A/S1PR2 signaling has been shown to lead to higher LTP without influencing LTD (Delekate et al. 2011; Kempf et al. 2014) , suggesting a general role for Nogo-A signaling in specifically controlling LTP magnitude. The Nogo-66 receptor NgR1, lacking a cytosolic domain (Venkatesh et al. 2005) , has been shown to signal via a heterotrimeric receptor complex composed of the transmembrane protein Lingo1 (Mi et al. 2004) , and the pan-neurotrophin receptor p75
NTR (Wang et al. 2002) . The receptor complex NgR1/ Lingo1/p75 NTR mediates the Nogo-A function in negatively regulating neurite outgrowth and axonal regeneration in the injured spinal cord (Thallmair et al. 1998; Mi et al. 2004) . In the context of activity-dependent synaptic plasticity in the adult mouse hippocampus all 3 members of the NgR1/Lingo1/p75 NTR receptor complex have been shown to be localized at synapses (Lee et al. 2008; Raiker et al. 2010) .Our experiments show that only Lingo1, and not p75 NTR is involved in transducing the Nogo-66/NgR1 signaling in restricting LTP. Similarly, the oligodendrocyte-myelin glycoprotein OMgp, another member of the myelin-associated inhibitors and ligand for NgR1, has been shown to restrict LTP Figure 7 . The molecular mechanism mediating the role of Nogo-A in stabilizing synapses. This cartoon depicts the intracellular pathway mediating Nogo-66 activity on LTP. Nogo-A has 2 inhibitory domains: Nogo-A-Δ20 signaling via S1PR2, and Nogo-66 signaling via NgR1. independently of p75 NTR (Raiker et al. 2010 (Meabon et al. 2015) which is difficult to reconcile with the model of a ternary cell-surface complex mediating myelin-associated inhibitor-dependent signaling. On the other hand, Lingo1 appears to be associated to membranes of the endocytic pathway leaving open the possibility that it might at least transiently be inserted at the plasma membrane. This observation suggests the possibility that Lingo1 exposure at the plasma membrane may be specifically regulated in an activity-dependent manner.
In our experiments, the acute neutralization of NgR1 leads to attenuated LTD, confirming previous studies showing that LTD is impaired in NgR1 knockout mice (Lee et al. 2008 (Fig. 7) . It is important to note that LTP and LTD in the hippocampus are age-dependent processes, with NMDA-dependent LTD being more inducible in the juvenile than in the adult hippocampus (Kemp et al. 2000) . Accordingly, while p75 NTR expression decreases during development (Woo et al. 2005; Zagrebelsky et al. 2005; Llorens et al. 2008) , Lingo1 expression remains constant in the mature CNS (Llorens et al. 2008) . This observation suggests the existence of different NgR1/coreceptors complexes in the hippocampus depending on the developmental stage thus possibly mediating different activity of NgR1. Indeed, our data show that the NgR1/ Lingo1 complex mediates the role of Nogo-66 in restricting synaptic strength in the CA1 region of the adult hippocampus. On the other hand, while our data suggest that LTD might be attenuated via the activation of a NgR1/p75 NTR complex this remains to be directly shown. On the other hand, because Nogo-66 does not affect LTD, a possible NgR1/p75 NTR dependent effect in this context is likely to be mediated by a different ligand than Nogo-A. Possible candidates for this effect might be the chondroitin sulfate proteoglycans which have been shown to bind NgR1 at a distinct binding site than Nogo-A (Dickendesher et al. 2012 ) and whose enzymatic digestion leads to impaired LTD (Bukalo et al. 2001) . Thus, the binding of different ligands might result in specific conformational changes of NgR1 promoting its interaction with either one or the other coreceptor.
Intracellular Pathway Mediating the Role of Nogo-66 Signaling on LTP
It is well established that long-term plasticity is associated with a rapid and persistent reorganization of actin within spines (Rudy 2014) . Indeed, LTP induction is followed by a brief decrease in Cofilin phosphorylation associated with an increase in actin depolymerization allowing trafficking of AMPAR (Gu et al. 2010) and other plasticity promoting molecules (e.g., CamKII; Ouyang et al. 2005 ) into activated synapses. Moreover, F-actin has been shown to be highly dynamic and to undergo a fast and transient reorganization upon LTP induction (Chen et al. 2015) . This early phase is followed by a transient increase in phosphorylated, inactive Cofilin allowing for actin polymerization and leading to an increase in the ratio of F-actin to G-actin into spines (Okamoto et al. 2004; Fukazawa et al. 2003) , critical for LTP maintenance and for activity-dependent structural changes. Here we show that within the adult hippocampus Nogo-66 modulates actin dynamics and increases the amount of activated, unphosphorylated Cofilin via ROCK2 signaling, possibly via the activation of the ROCK2 downstream target Slingshot (SSH) phosphatase. Indeed, it was shown that Nogo-66 inhibits neuronal outgrowth by first decreasing and then increasing Cofilin activation levels via a ROCK-dependent sequential activation of LIM Kinase (LIMK) and SSH phosphatase (Hsieh et al. 2006 ). In addition, in Nogo-A knockout mice inactivated Cofilin is increased leading to actin polymerization within the growth cone supporting neurite formation and extension (Montani et al. 2009 ). Finally, NgR1 restricts the formation of excitatory synapses in developing hippocampal neurons via a RhoA-dependent pathway (Wills et al. 2012) implicating the regulation of the ROCK-Cofilin pathway by NgR1 signaling also at synapses. Next, our results indicate that Nogo-66 regulates actin dynamics and the Cofilin activation status in the context of activity-dependent synaptic plasticity. Indeed, a short application of Nogo-66 around LTP induction results in impaired LTP maintenance preventing the expected increase in Cofilin phosphorylation and the activity-dependent actin polymerization resulting in the instability of the actin cytoskeleton. Indeed, applying the actin stabilizing agent Jasplakinolide completely rescues the impairment of LTP maintenance observed upon Nogo-66 treatment. Accordingly, treatments that inhibit the polymerization of actin filaments before or shortly after induction have been shown to generate but to fail to maintain LTP over time (Rudy 2014; Kim and Lisman 1999; Krucker et al. 2000; Kramár et al. 2006) suggesting that the actin polymerization and reorganization upon LTP induction does not affect generation of LTP but is crucial for its maintenance.
It has been shown that a shRNA mediated downregulation of Nogo-A increases the expression of NMDAR and AMPAR subunits in hippocampal neurons (Peng et al. 2011) . Moreover, the trafficking of AMPAR upon LTP has been shown to be regulated by the biphasic modulation of actin dynamics via Cofilin (Gu et al. 2010) and by NgR1 signaling (Jitsuki et al. 2015) . These observations suggest that the Nogo-66/NgR1 signaling might restrict LTP by influencing the ROCK-Cofilin pathway to negatively regulate the insertion of AMPAR at post-synaptic sites.
In conclusion, our data identify one of the extracellular cues controlling actin dynamics during activity-dependent functional plasticity processes. While BDNF/TrkB signaling positively regulates LTP maintenance in the hippocampus by promoting actin polymerization within dendritic spines , in this study we show that Nogo-66/NgR1 signaling restricts LTP by activating the ROCK2-Cofilin pathway to prevent activity-dependent actin polymerization (Fig. 7) . Our work deepens the knowledge on how Nogo-A protein limits the experience-dependent plasticity to stabilize neural circuits in the adult hippocampus, a structure known to remain plastic throughout life. Indeed, a tightly regulated balance between plasticity and stability of neural circuits in the mature brain ensures the spatial and temporal specificity necessary for learning memory storage processes. For instance, signaling from myelin-associate neurite growth inhibitors has been shown to be upregulated in cognitively impaired aged rats (Vanguilder et al. 2012) , suggesting that an excessive stabilization of synaptic networks might prevent the acquisition and consolidation of new memories. In parallel, in a microRNAmediated Nogo-A knockdown rats, the depletion of Nogo-A is associated with symptoms correlated to schizophrenia (Tews et al. 2013) , suggesting that a reduction of the mechanisms that control stability of neuronal network might be detrimental for cognitive functions.
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